Press release: invIOs to present at upcoming conferences

Vienna, Austria, 03 February 2022: invIOs GmbH, a privately held biotechnology company developing novel therapies for cancer, today announced the participation at three upcoming investor conferences, the BIO CEO & Investor Conference, Sachs 15th Annual European Life Sciences CEO Forum and LSX World Congress. invIOs management will hold company presentations at these events and participate in one panel discussion. Further, the company will attend BIO-Europe Spring and Bio€quity Europe.

For further information, please see:

Press release (EN) | Presseaussendung (DE)